Due to this cut-off, 23 out of 36 breast tumor specimens exhibited ITIH2 downregulation (63.9%) by FC2, whereas 13 out of 36 specimens (36.1%) showed no deregulation or upregulation of ITIH2 (Figure 3). Here, ITIH2 is linked to breast neoplasm.